Correlation Between Clal Biotechnology and Nova

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Clal Biotechnology and Nova at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Clal Biotechnology and Nova into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Clal Biotechnology Industries and Nova, you can compare the effects of market volatilities on Clal Biotechnology and Nova and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Clal Biotechnology with a short position of Nova. Check out your portfolio center. Please also check ongoing floating volatility patterns of Clal Biotechnology and Nova.

Diversification Opportunities for Clal Biotechnology and Nova

-0.29
  Correlation Coefficient

Very good diversification

The 3 months correlation between Clal and Nova is -0.29. Overlapping area represents the amount of risk that can be diversified away by holding Clal Biotechnology Industries and Nova in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nova and Clal Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Clal Biotechnology Industries are associated (or correlated) with Nova. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nova has no effect on the direction of Clal Biotechnology i.e., Clal Biotechnology and Nova go up and down completely randomly.

Pair Corralation between Clal Biotechnology and Nova

Assuming the 90 days trading horizon Clal Biotechnology Industries is expected to under-perform the Nova. In addition to that, Clal Biotechnology is 1.37 times more volatile than Nova. It trades about -0.01 of its total potential returns per unit of risk. Nova is currently generating about 0.11 per unit of volatility. If you would invest  3,460,000  in Nova on November 27, 2024 and sell it today you would earn a total of  5,938,000  from holding Nova or generate 171.62% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Clal Biotechnology Industries  vs.  Nova

 Performance 
       Timeline  
Clal Biotechnology 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Clal Biotechnology Industries has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's forward indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.
Nova 

Risk-Adjusted Performance

Solid

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Nova are ranked lower than 19 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Nova sustained solid returns over the last few months and may actually be approaching a breakup point.

Clal Biotechnology and Nova Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Clal Biotechnology and Nova

The main advantage of trading using opposite Clal Biotechnology and Nova positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Clal Biotechnology position performs unexpectedly, Nova can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nova will offset losses from the drop in Nova's long position.
The idea behind Clal Biotechnology Industries and Nova pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.

Other Complementary Tools

Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum